Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
Description
CONCLUSIONS: The IgNiTE (ImmunoglobuliN in the Treatment of Encephalitis) study findings support existing evidence of poor neurological outcomes in children with encephalitis. However, the study was halted prematurely and was therefore underpowered
